Interleukin-1β attenuates β-very low-density lipoprotein uptake and its receptor expression in vascular smooth muscle cells

Austin, 1991, Plasma triglyceride and coronary heart disease, Arterioscler Thromb, 11, 2, 10.1161/01.ATV.11.1.2 Banfi, 1999, Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells, Circ Res, 85, 208, 10.1161/01.RES.85.2.208 Dichtl, 1999, Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells, Circ Res, 84, 1085, 10.1161/01.RES.84.9.1085 Grundy, 1992, Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment, Arch Intern Med, 152, 28, 10.1001/archinte.1992.00400130054004 Brunzell, 1983, Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia, J Lipid Res, 24, 147, 10.1016/S0022-2275(20)38008-1 Brunzell, 1976, Myocardial infarction in the familial forms of hypertriglyceridemia, Metabolism, 25, 313, 10.1016/0026-0495(76)90089-5 Garg, 1990, Management of dyslipidemia in NIDDM, Diabetes Care, 13, 153, 10.2337/diacare.13.2.153 Takahashi, 1992, Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity, Proc Natl Acad Sci USA, 89, 9252, 10.1073/pnas.89.19.9252 Suzuki, 1995, Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor, Biochem Biophys Res Commun, 206, 835, 10.1006/bbrc.1995.1119 Multhaupt, 1996, Expression of very low density lipoprotein receptor in the vascular wall. Analysis of human tissues by in situ hybridization and immunohistochemistry, Am J Pathol, 148, 1985 Kosaka, 2001, Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages, Circulation, 103, 1142, 10.1161/01.CIR.103.8.1142 Jaakkola, 1988, Lipoprotein uptake in primary cell cultures of rabbit atherosclerotic lesions. A fluorescence microscopic and flow cytometric study, Atherosclerosis, 69, 257, 10.1016/0021-9150(88)90022-6 Hiltunen, 1998, Expression of lipoprotein receptors in atherosclerotic lesions, Atherosclerosis, 137, S81, 10.1016/S0021-9150(97)00307-9 Lipskaia, 2003, Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation, Circ Res, 92, 1115, 10.1161/01.RES.0000074880.25540.D0 Takahashi, 2002, Beta-very low density lipoprotein enhances inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells, Atherosclerosis, 162, 307, 10.1016/S0021-9150(01)00727-4 Oida, 1997, Effect of oxidized low density lipoprotein on thrombomodulin expression by THP-1 cells, Thromb Haemost, 78, 1228, 10.1055/s-0038-1657719 Dawson, 1984, Lowry method of protein quantification: evidence for photosensitivity, Anal Biochem, 140, 391, 10.1016/0003-2697(84)90183-0 Takahashi, 1996, Mitogen-activated protein kinase (ERK1/2) activation by shear stress and adhesion in endothelial cells. Essential role for a herbimycin-sensitive kinase, J Clin Invest, 98, 2623, 10.1172/JCI119083 Okuda, 1999, Shear stress stimulation of p130(cas) tyrosine phosphorylation requires calcium-dependent c-Src activation, J Biol Chem, 274, 26803, 10.1074/jbc.274.38.26803 Ogata, 2003, Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro, Hypertension, 41, 1156, 10.1161/01.HYP.0000064342.30653.24 Takahashi, 2001, Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes, Cardiovasc Res, 52, 438, 10.1016/S0008-6363(01)00408-4 Kamataki, 2002, Remnant lipoprotein particles are taken up into myocardium through VLDL receptor—a possible mechanism for cardiac fatty acid metabolism, Biochem Biophys Res Commun, 293, 1007, 10.1016/S0006-291X(02)00323-6 Blagosklonny, 2002, Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs, Leukemia, 16, 455, 10.1038/sj.leu.2402415 Gui, 2000, Interleukin-1beta, Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro, Am J Physiol Heart Circ Physiol, 279, H566, 10.1152/ajpheart.2000.279.2.H566 Yoshida, 2003, Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase, J Biol Chem, 278, 36953, 10.1074/jbc.M305214200 Frykman, 1995, Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor, Proc Natl Acad Sci USA, 92, 8453, 10.1073/pnas.92.18.8453 Tacken, 2002, VLDL receptor deficiency enhances intimal thickening after vascular injury but does not affect atherosclerotic lesion area, Atherosclerosis, 162, 103, 10.1016/S0021-9150(01)00697-9 Ross, 1990, Mechanisms of atherosclerosis—a review, Adv Nephrol Necker Hosp, 19, 79 Takahashi, 1994, Involvement of adhesion molecules in human monocyte adhesion to and transmigration through endothelial cells in vitro, Atherosclerosis, 108, 73, 10.1016/0021-9150(94)90038-8 Takahashi, 1995, Induction of monocyte chemoattractant protein-1 synthesis in human monocytes during transendothelial migration in vitro, Circ Res, 76, 750, 10.1161/01.RES.76.5.750 Seino, 1995, Expression of monocyte chemoattractant protein-1 in vascular tissue, Cytokine, 7, 575, 10.1006/cyto.1995.0078 Whitesell, 1994, Inhibition of heat shock protein HSP90-pp60v-Src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation, Proc Natl Acad Sci USA, 91, 8324, 10.1073/pnas.91.18.8324 Stancato, 1993, Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system, J Biol Chem, 268, 21711, 10.1016/S0021-9258(20)80600-0 Wartmann, 1994, The native structure of the activated Raf protein kinase is a membrane-bound multi-subunit complex, J Biol Chem, 269, 6695, 10.1016/S0021-9258(17)37431-8 Shiotsu, 2000, Novel oxime derivatives of radicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of Bcr-Abl with Hsp90 complex, Blood, 96, 2284, 10.1182/blood.V96.6.2284 An, 2000, The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-Src proteins before their degradation by the proteasome, Cell Growth Differ, 11, 355 Xu, 2001, Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90, J Biol Chem, 276, 3702, 10.1074/jbc.M006864200 Dinarello, 1993, The role of interleukin-1 in disease, New Engl J Med, 328, 106, 10.1056/NEJM199301143280207 Ross, 1999, Atherosclerosis—an inflammatory disease, New Engl J Med, 340, 115, 10.1056/NEJM199901143400207